Wang, Q., Qian, L., Chen, S., Chu, C., Wilson, B., Oyarzabal, E., . . . Hong, J. (2015). Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson’s disease models. Brain.

Wang, Qingshan, et al. "Post-treatment With an Ultra-low Dose of NADPH Oxidase Inhibitor Diphenyleneiodonium Attenuates Disease Progression in Multiple Parkinson’s Disease Models." Brain 2015.

Wang, Qingshan, et al. "Post-treatment With an Ultra-low Dose of NADPH Oxidase Inhibitor Diphenyleneiodonium Attenuates Disease Progression in Multiple Parkinson’s Disease Models." Brain 2015.